Invention Grant
![Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanone](/docs/US/2020-03-17/US10590102B2/abs.jpg.600x600.jpg)
- Patent Title: Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanone
-
Application No.: US15852280Application Date: 2017-12-22
-
Publication No.: US10590102B2Publication Date: 2020-03-17
- Inventor: Adrian St. Clair Brown
- Applicant: Exelixis, Inc.
- Applicant Address: US CA Alameda
- Assignee: EXELIXIS, INC.
- Current Assignee: EXELIXIS, INC.
- Current Assignee Address: US CA Alameda
- Agency: Honigman LLP
- Agent Heidi M. Berven; Andrew S. Chipouras
- Main IPC: C07D401/04
- IPC: C07D401/04 ; A61P35/02
![Crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]methanone](/abs-image/US/2020/03/17/US10590102B2/abs.jpg.150x150.jpg)
Abstract:
This disclosure relates to the crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone. The disclosure also relates to pharmaceutical compositions comprising the crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone. The disclosure also relates to methods of treating cancers comprising administering to a patient in need thereof the crystalline fumarate salt of (S)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone.
Public/Granted literature
Information query
